113.08
price up icon1.56%   1.74
 
loading
前日終値:
$111.34
開ける:
$110.76
24時間の取引高:
863.98K
Relative Volume:
1.05
時価総額:
$27.11B
収益:
$3.30B
当期純損益:
$-501.07M
株価収益率:
9.8003
EPS:
11.5384
ネットキャッシュフロー:
$1.03B
1週間 パフォーマンス:
-6.06%
1か月 パフォーマンス:
+10.71%
6か月 パフォーマンス:
+31.67%
1年 パフォーマンス:
+10.00%
1日の値動き範囲:
Value
$109.80
$115.34
1週間の範囲:
Value
$109.52
$119.64
52週間の値動き範囲:
Value
$76.53
$131.49

Biontech Se Adr Stock (BNTX) Company Profile

Name
名前
Biontech Se Adr
Name
セクター
Healthcare (1176)
Name
電話
-
Name
住所
-
Name
職員
6,133
Name
Twitter
@BioNTech_Group
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
BNTX's Discussions on Twitter

BNTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-11 開始されました Wells Fargo Overweight
2024-12-02 繰り返されました BMO Capital Markets Outperform
2024-11-19 開始されました Berenberg Buy
2024-11-19 アップグレード Evercore ISI In-line → Outperform
2024-11-08 アップグレード Goldman Neutral → Buy
2024-09-24 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-09-17 アップグレード Jefferies Hold → Buy
2024-09-16 アップグレード JP Morgan Underweight → Neutral
2024-08-07 アップグレード Deutsche Bank Hold → Buy
2024-08-02 アップグレード HSBC Securities Hold → Buy
2024-05-14 開始されました Evercore ISI In-line
2024-02-23 開始されました BMO Capital Markets Outperform
2024-01-05 開始されました Oppenheimer Perform
2023-12-01 ダウングレード JP Morgan Neutral → Underweight
2023-10-16 ダウングレード HSBC Securities Buy → Hold
2023-07-14 開始されました HSBC Securities Buy
2023-05-17 アップグレード Redburn Neutral → Buy
2022-12-15 アップグレード BofA Securities Neutral → Buy
2022-08-17 開始されました Cowen Market Perform
2022-07-13 アップグレード SVB Leerink Mkt Perform → Outperform
2022-07-06 再開されました Canaccord Genuity Buy
2022-02-01 アップグレード Redburn Sell → Neutral
2021-12-16 開始されました Morgan Stanley Equal-Weight
2021-11-10 アップグレード H.C. Wainwright Neutral → Buy
2021-10-22 開始されました Deutsche Bank Hold
2021-10-07 開始されました Jefferies Hold
2021-08-11 アップグレード Bryan Garnier Neutral → Buy
2021-07-19 再開されました Wolfe Research Outperform
2021-06-16 ダウングレード Redburn Neutral → Sell
2021-05-18 開始されました Goldman Neutral
2021-05-11 ダウングレード Bryan Garnier Buy → Neutral
2020-12-01 ダウングレード BofA Securities Buy → Neutral
2020-08-03 再開されました Berenberg Buy
2020-07-21 アップグレード BofA Securities Neutral → Buy
2020-06-30 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-19 アップグレード H.C. Wainwright Neutral → Buy
2020-04-28 ダウングレード BofA/Merrill Buy → Neutral
2020-03-18 ダウングレード JP Morgan Overweight → Neutral
2020-03-09 開始されました H.C. Wainwright Neutral
2020-01-24 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-01-22 ダウングレード UBS Buy → Neutral
2019-11-05 開始されました Wolfe Research Outperform
2019-11-04 開始されました Berenberg Buy
2019-11-04 開始されました BofA/Merrill Buy
2019-11-04 開始されました Canaccord Genuity Buy
2019-11-04 開始されました JP Morgan Overweight
2019-11-04 開始されました SVB Leerink Outperform
2019-11-04 開始されました UBS Buy
すべてを表示

Biontech Se Adr (BNTX) 最新ニュース

pulisher
Dec 19, 2024

BioNTech SE ADR falls Thursday, underperforms market - MarketWatch

Dec 19, 2024
pulisher
Dec 18, 2024

BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch

Dec 18, 2024
pulisher
Dec 18, 2024

3 No-Brainer Biotech Stocks to Buy With $200 Right Now - The Motley Fool

Dec 18, 2024
pulisher
Dec 18, 2024

Stocks Generating Improved Relative Strength: BioNTech ADR - Investor's Business Daily

Dec 18, 2024
pulisher
Dec 17, 2024

BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch

Dec 17, 2024
pulisher
Dec 16, 2024

BioNTech SE ADR falls Monday, underperforms market - MarketWatch

Dec 16, 2024
pulisher
Dec 16, 2024

BioNTech's SWOT analysis: mRNA pioneer's stock faces oncology pipeline test - Investing.com

Dec 16, 2024
pulisher
Dec 13, 2024

BioNTech SE ADR falls Friday, underperforms market - MarketWatch

Dec 13, 2024
pulisher
Dec 12, 2024

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

Dec 12, 2024
pulisher
Dec 11, 2024

BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch

Dec 11, 2024
pulisher
Dec 10, 2024

BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch

Dec 10, 2024
pulisher
Dec 06, 2024

BioNTech SE ADR rises Friday, outperforms market - MarketWatch

Dec 06, 2024
pulisher
Dec 03, 2024

BioNTech's SWOT analysis: mRNA pioneer's stock balances COVID legacy, oncology future - Investing.com

Dec 03, 2024
pulisher
Nov 25, 2024

BioNTech SE ADR rises Monday, outperforms market - MarketWatch

Nov 25, 2024
pulisher
Nov 25, 2024

Stocks Showing Improving Market Leadership: BioNTech ADR Earns 81 RS Rating - Investor's Business Daily

Nov 25, 2024
pulisher
Nov 22, 2024

BioNTech ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily

Nov 22, 2024
pulisher
Nov 21, 2024

BioNTech's SWOT analysis: oncology pipeline fuels stock's potential amid market volatility - Investing.com

Nov 21, 2024
pulisher
Nov 20, 2024

BioNTech Stock Got A IBD RS Rating Lift - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

BioNTech ADR Shows Improved Relative Strength; Still Shy Of Benchmark - Inkl

Nov 20, 2024
pulisher
Nov 19, 2024

Analysts Turn Bullish on BioNTech Stock Amid Volatility - Schaeffers Research

Nov 19, 2024
pulisher
Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024
pulisher
Nov 16, 2024

BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register

Nov 16, 2024
pulisher
Nov 15, 2024

Powell Speaks The Truth - Benzinga

Nov 15, 2024
pulisher
Nov 15, 2024

Goodwin, Conyers, A&O Shearman Act on $800M China Biotech Sale - Law.com International

Nov 15, 2024
pulisher
Nov 14, 2024

BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up - Yahoo Finance

Nov 14, 2024
pulisher
Nov 08, 2024

Stock Futures Quiet as Market Heads for Winning Week - Schaeffers Research

Nov 08, 2024
pulisher
Nov 05, 2024

BioNTech Earnings: Strong Covid Revenue, but Full-Year Expectations Unchanged - Morningstar

Nov 05, 2024
pulisher
Nov 04, 2024

BioNTech SE Reports Strong Q3 2024 Results - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

This 6%-yielding U.S. pharma giant is a safe hold - The Globe and Mail

Nov 04, 2024
pulisher
Nov 04, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 04, 2024
pulisher
Oct 31, 2024

BioNTech SE ADR outperforms market despite losses on the day - MarketWatch

Oct 31, 2024
pulisher
Oct 29, 2024

Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase - Yahoo Finance

Oct 29, 2024
pulisher
Oct 28, 2024

Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? - Nasdaq

Oct 28, 2024
pulisher
Oct 28, 2024

BioNTech to Report Q3 Earnings: Is a Beat in the Cards? - MSN

Oct 28, 2024

Biontech Se Adr (BNTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$245.44
price up icon 2.75%
$176.50
price up icon 1.02%
$623.82
price down icon 0.35%
$359.58
price down icon 0.16%
$39.39
price down icon 0.43%
大文字化:     |  ボリューム (24 時間):